{"disease":{"id":"gastrointestinal-tumors","name":"Gastrointestinal Tumors","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:31:21.551Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":0,"pipeline_drug_count":2,"trial_count":0},"drugs":{"marketed":[],"pipeline":[{"drug_id":"anti-pd1","indication_name":"Gastrointestinal Tumors","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anti-PD1","generic_name":"anti-pd1","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Anti-PD1 PF-06801591","quality_score":null,"revenue":null,"mechanism":"Anti-PD1 PF-06801591"},{"drug_id":"anti-vegf","indication_name":"Gastrointestinal Tumors","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Anti-VEGF","generic_name":"anti-vegf","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Anti-VEGF IV (bevacizumab)","quality_score":null,"revenue":null,"mechanism":"Anti-VEGF IV (bevacizumab)"},{"drug_id":"pf-07062119","indication_name":"Advanced or metastatic gastrointestinal tumors","indication_type":"pipeline","phase":"Phase 1","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07062119","generic_name":"pf-07062119","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"Undisclosed molecular target (pathway inhibitor in gastrointestinal cancer)","drug_class":"Selective pathway inhibitor","quality_score":null,"revenue":null,"mechanism":"PF-07062119 is a selective inhibitor targeting a key molecular pathway in gastrointestinal cancer cell proliferation."}],"offLabel":[],"totalMarketed":0,"totalPipeline":3},"trials":{"data":[{"nct_id":"NCT06478030","title":"Combined Screening for Gastrointestinal Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT07524114","title":"Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT07072143","title":"An International Study on Pediatric Patients With Rare Tumors.","phase":"","overall_status":"RECRUITING","enrollment_count":6250,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT04181970","title":"Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Grupo Espanol de Investigacion en Sarcomas","has_results":false},{"nct_id":"NCT03602092","title":"Observational Registry Data on GIST Patients","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"National Health Research Institutes, Taiwan","has_results":false},{"nct_id":"NCT05693519","title":"GastroIntestinal Cancer in Children and Adolescents","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Paul G. Kemps, MD","has_results":false},{"nct_id":"NCT00700258","title":"Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]","phase":"","overall_status":"COMPLETED","enrollment_count":1520,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06263205","title":"Non-Dressing vs. Routine Dressing Change After Gastrointestinal Cancer Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":1138,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT05400018","title":"Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients","phase":"","overall_status":"COMPLETED","enrollment_count":1041,"lead_sponsor_name":"Genetron Health","has_results":false},{"nct_id":"NCT06523582","title":"Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients","phase":"","overall_status":"RECRUITING","enrollment_count":750,"lead_sponsor_name":"Universidad Nacional Autonoma de Mexico","has_results":false},{"nct_id":"NCT07353346","title":"Evaluation of Short-term and Long-term Efficacy of Endoscopic Treatment for Gastrointestinal Submucosal Tumors","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT05922358","title":"Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05565066","title":"A Real-world Comparison of FNB and FNA in IHC-required Lesions.","phase":"","overall_status":"COMPLETED","enrollment_count":439,"lead_sponsor_name":"Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06085365","title":"Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":324,"lead_sponsor_name":"China Medical University, China","has_results":false},{"nct_id":"NCT05697107","title":"Ripretinib in Chinese Patients With Advanced GIST: a Real World Study","phase":"","overall_status":"UNKNOWN","enrollment_count":308,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT07454967","title":"Development of a Multimodal AI System for GIST Management","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Qun Zhao","has_results":false},{"nct_id":"NCT03412877","title":"Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05751733","title":"Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST","phase":"NA","overall_status":"RECRUITING","enrollment_count":258,"lead_sponsor_name":"Xiangya Hospital of Central South University","has_results":false},{"nct_id":"NCT03114319","title":"Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":227,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06263088","title":"EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT01271712","title":"Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT05938309","title":"A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT01178307","title":"Symptom Inventory for Gastrointestinal Stromal Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":187,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04409223","title":"Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":185,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05197933","title":"Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach","phase":"NA","overall_status":"UNKNOWN","enrollment_count":182,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT03247231","title":"Banding Without Resection in Small Subepithelial Tumours","phase":"","overall_status":"TERMINATED","enrollment_count":157,"lead_sponsor_name":"Joan B Gornals","has_results":false},{"nct_id":"NCT04207463","title":"A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT06324032","title":"SUNNYDAY: SUbepithelialgastroiNtestiNal Tumors Detection,accuracYDiAgnosis,ElastographY and Contrast-enhanced EUS","phase":"","overall_status":"UNKNOWN","enrollment_count":138,"lead_sponsor_name":"Fondazione del Piemonte per l'Oncologia","has_results":false},{"nct_id":"NCT07411118","title":"RCT of EFTR Versus STER for GIST Treatment","phase":"NA","overall_status":"RECRUITING","enrollment_count":136,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03353753","title":"Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Deciphera Pharmaceuticals, LLC","has_results":true},{"nct_id":"NCT04000529","title":"Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":122,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT06479811","title":"[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT01275222","title":"Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05262335","title":"Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":116,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05440357","title":"Second-line Pharmacotherapy Patterns and Outcomes of Advanced Gastrointestinal Stromal Tumor: A Real-world Study","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Xinhua Zhang, MD","has_results":false},{"nct_id":"NCT03977077","title":"Treatment of Advanced Gastrointestinal Tumors With Albumin Taxol","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT06772233","title":"A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03597581","title":"A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Inspirna, Inc.","has_results":false},{"nct_id":"NCT03601234","title":"Laparoscopic Endoscopic Cooperative Surgery in the Treatment of Gastric Stromal Tumors","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT04171141","title":"Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":79,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05464875","title":"A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":74,"lead_sponsor_name":"Xinhua Zhang, MD","has_results":false},{"nct_id":"NCT05461664","title":"Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA","phase":"","overall_status":"RECRUITING","enrollment_count":74,"lead_sponsor_name":"Xinhua Zhang, MD","has_results":false},{"nct_id":"NCT01933958","title":"Regorafenib Post-marketing Surveillance in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT03833700","title":"A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"Eisai Co., Ltd.","has_results":false},{"nct_id":"NCT06805825","title":"A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":67,"lead_sponsor_name":"Novelty Nobility, Inc.","has_results":false},{"nct_id":"NCT06427798","title":"Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":66,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04254939","title":"A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"CStone Pharmaceuticals","has_results":false},{"nct_id":"NCT05665868","title":"Study on Integrated Nursing Strategy for Patients With Gastrointestinal Stromal Tumors After Targeted Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":62,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT05381753","title":"Safety and Efficacy of Avapritinib in Chinese Patients With Gastrointestinal Stromal Tumor (GIST) in the Real World","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"CStone Pharmaceuticals","has_results":false},{"nct_id":"NCT04106024","title":"Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Cttq","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}